Evidence map›Paper›PMID 30662524›Full record

ArticleJournal of Cancer2019

Circulating miR-1290 and miR-320d as Novel Diagnostic Biomarkers of Human Colorectal Cancer.

Xiangxiang Liu, Xueni Xu, Bei Pan, Bangshun He, Xiaoxiang Chen, Kaixuan Zeng, Mu Xu, Yuqin Pan, Huiling Sun, Tao Xu and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Xiangxiang LiuCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Xueni XuMedical School of Southeast University, 210009, China.
Bei PanCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Bangshun HeCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Xiaoxiang ChenMedical School of Southeast University, 210009, China.
Kaixuan ZengMedical School of Southeast University, 210009, China.
Mu XuCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Yuqin PanCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Huiling SunCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Tao XuCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Xiuxiu HuMedical School of Southeast University, 210009, China.
Shukui WangCentral Laboratory, Nanjing First Hospital, Nanjing Medical University, Nanjing 210000, China.
Nanjing Medical University · CNSoutheast University · BDInventec (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

circulationcolorectal cancerdiagnostic biomarkermicroRNA

Identifiers

PMID30662524
PMCPMC6329864
OpenAlexW2904758784

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.